E Fund Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,383
| Closed | -$50.5K | – | 410 |
|
|
2025
Q1 | $50.5K | Buy |
10,383
+145
| +1% | +$705 | ﹤0.01% | 392 |
|
|
2024
Q4 | $97.9K | Buy |
+10,238
| New | +$97.9K | ﹤0.01% | 379 |
|
|
2023
Q3 | – | Sell |
-31,274
| Closed | -$230K | – | 300 |
|
|
2023
Q2 | $230K | Buy |
31,274
+9,528
| +44% | +$70.1K | 0.02% | 260 |
|
|
2023
Q1 | $225K | Sell |
21,746
-20
| -0.1% | -$207 | 0.02% | 277 |
|
|
2022
Q4 | $257K | Buy |
21,766
+5,618
| +35% | +$66.3K | 0.02% | 254 |
|
|
2022
Q3 | $339K | Buy |
16,148
+1,508
| +10% | +$31.7K | 0.03% | 216 |
|
|
2022
Q2 | $454K | Buy |
14,640
+7,286
| +99% | +$226K | 0.04% | 160 |
|
|
2022
Q1 | $302K | Buy |
+7,354
| New | +$302K | 0.01% | 192 |
|